AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (83)

Latest Posts

About This Stock More About This Stock
Week In Review: China Life Science Venture Tie-Up, WuXi And Frontline Merge
Article By: ChinaBio® Today
Saturday, May 27, 2017 6:08 PM EDT
Two prominent China-US healthcare investment firms plan to join forces. WuXi Healthcare Ventures and Frontline BioVentures will merge to form 6 Dimensions Capital.
In this article: JNJ, ABBV
Read
Large Cap Biopharmaceutical Valuations: Q1 2017
Article By: Rod Raynovich
Monday, May 8, 2017 8:45 PM EDT
Large cap biopharmaceutical stocks are about 3-4% off their 2017 highs but have been losing momentum. Here is a quick review of the valuation metrics.
In this article: BMY, RHHBY, FBIOX, ALXN, IBB, REGN, AMGN, BIIB, CELG, GILD, FBT, XBI, ABBV
Read
2017 Biotech Breakout Coming
Article By: Rod Raynovich
Monday, May 1, 2017 8:56 PM EDT
We expect a biotech breakout to 52 week highs in the coming months because of new products, good clinical news and M&A. Biotech has survived several tweet storms from Trump and many negative articles on drug pricing.
In this article: BMY, BMRN, IBB, INCY, REGN, SGEN, GILD, VRTX, XBI, ABBV, QQQ
Read
A Deluge And An Eclipse
Article By: Marvin R Clark
Thursday, April 27, 2017 11:33 PM EDT
Today brought a deluge of earnings.Google parent Alphabet posted a 29 percent rise in quarterly profit, driven by a surge in advertising on mobiles and its popular YouTube video service.
In this article: BMY, DPZ, F, KKR, LNKD, LUV, UPS, AMZN, GOOG, INTC, MSFT, SBUX, AAL, ABBV, GOOGL, CCV
Read
AbbVie’s Humira Revenue Up 15% (Despite Patent Cliff Fears)
Article By: SureDividend
Thursday, April 27, 2017 3:54 PM EDT
Will discuss why AbbVie’s earnings report was better than anticipated, and what investors can expect from this stock moving forward.
In this article: ABBV Also: ABT
Read

PARTNER HEADLINES

Latest Tweets for $ABBV

No tweets yet!

$ABBV

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments